Daily aspirin reduces risk of ovarian cancer, regardless of genetics

Published Date: 08 Mar 2023

New findings show that frequent aspirin use provides protection against ovarian cancer, regardless of a person's genetic risk.

Read Full News

Latest News

Democrats Press RFK Jr. on an Ethics Agreement Change Involving Law Firm Fees

Lawmakers say Kennedy quietly changed his ethics disclosures after his confirmation hearings

Two Procedures May Yield Similar Symptom Relief for Uterine Fibroids

— Radiofrequency ablation and myomectomy outcomes assessed in 2-year study

Maternal Tdap Blunts Preschoolers' Pertussis Shot Response, but Booster Revives Them

A DTaP booster at age 4 brought immune responses level with kids of unvaccinated moms

FDA Nominee Voices Support for Vaccines at Senate Hearing Scrutinizing Trump's Moves

Overton declined to explicitly say that Trump was wrong about the MMR vaccine's safety, however

Hereditary Insight: Navigating High- and Moderate-Risk Genes for Breast Cancer Treatment

Hereditary Insight: Navigating High- and Moderate-Risk Genes for Breast Cancer Treatment

Gauging Benefits of Risk-Reducing Surgery for BRCA-Related Ovarian Cancer

For at-risk women who delay surgery, risk remains substantial at 50, especially with BRCA1

Todays Updates

IZAR-1: Sonelokimab Meets Phase 3 End Points for PsA

IZAR-1: Sonelokimab Meets Phase 3 End Points for PsA

What 2 Seasons of Arexvy Data Reveal About RSV-Related Risk Reduction Ann Falsey, MD

Two-season real-world data show Arexvy reduces RSV-related MACE and COPD and asthma exacerbations in adults 60 and older, Ann Falsey, MD, says.

Dupilumab Outperforms Omalizumab for Asthma Remission in Phase 4 EVEREST Guy Brusselle, MD, PhD

Guy Brusselle, MD, PhD, says that 64% of dupilumab-treated patients met composite asthma clinical remission criteria at week 24 versus 40.5% with omalizumab.

What The FDA Psychedelic Hearing Means for Psychiatrists

What The FDA Psychedelic Hearing Means for Psychiatrists

Phase 4 OCTAGON Trial to Test Rapid Steroid Taper With Ravulizumab Marco Meglio

A new phase 4 trial, OCTAGON, will test a rapid, predefined corticosteroid-tapering schedule in patients with generalized myasthenia gravis treated with ravulizumab.

Phase 4 Study Evaluates Transition From IVIG to Subcutaneous Efgartigimod in CIDP Louie Pasculli

A phase 4 study is evaluating whether adults with chronic inflammatory demyelinating polyneuropathy can transition from intravenous immunoglobulin to subcutaneous efgartigimod PH20 without first experiencing disease worsening.

Phase 4 Study Shows Stable Motor Function in Adults With SMA on Risdiplam Isabella Ciccone, MPH

Real-world 12‑month results from WeSMA, a phase 4 study, showed that oral risdiplam is well tolerated in adults with SMA, with stable motor function and consistent safety findings.

Todays Updates

IZAR-1: Sonelokimab Meets Phase 3 End Points for PsA

IZAR-1: Sonelokimab Meets Phase 3 End Points for PsA

What 2 Seasons of Arexvy Data Reveal About RSV-Related Risk Reduction Ann Falsey, MD

Two-season real-world data show Arexvy reduces RSV-related MACE and COPD and asthma exacerbations in adults 60 and older, Ann Falsey, MD, says.

Dupilumab Outperforms Omalizumab for Asthma Remission in Phase 4 EVEREST Guy Brusselle, MD, PhD

Guy Brusselle, MD, PhD, says that 64% of dupilumab-treated patients met composite asthma clinical remission criteria at week 24 versus 40.5% with omalizumab.

What The FDA Psychedelic Hearing Means for Psychiatrists

What The FDA Psychedelic Hearing Means for Psychiatrists

Phase 4 OCTAGON Trial to Test Rapid Steroid Taper With Ravulizumab Marco Meglio

A new phase 4 trial, OCTAGON, will test a rapid, predefined corticosteroid-tapering schedule in patients with generalized myasthenia gravis treated with ravulizumab.

Phase 4 Study Evaluates Transition From IVIG to Subcutaneous Efgartigimod in CIDP Louie Pasculli

A phase 4 study is evaluating whether adults with chronic inflammatory demyelinating polyneuropathy can transition from intravenous immunoglobulin to subcutaneous efgartigimod PH20 without first experiencing disease worsening.

Phase 4 Study Shows Stable Motor Function in Adults With SMA on Risdiplam Isabella Ciccone, MPH

Real-world 12‑month results from WeSMA, a phase 4 study, showed that oral risdiplam is well tolerated in adults with SMA, with stable motor function and consistent safety findings.

Latest News

Lawmakers say Kennedy quietly changed his ethics disclosures after his confirmation hearings

— Radiofrequency ablation and myomectomy outcomes assessed in 2-year study

A DTaP booster at age 4 brought immune responses level with kids of unvaccinated moms

Overton declined to explicitly say that Trump was wrong about the MMR vaccine's safety, however

Hereditary Insight: Navigating High- and Moderate-Risk Genes for Breast Cancer Treatment

For at-risk women who delay surgery, risk remains substantial at 50, especially with BRCA1

News All Time

U.S. Women Increasingly Not Screened for Cervical Cancer

Nearly one-third of women ages 21 to 29 had never undergone screening

These Women Face Higher Risk for Anal Sphincter Tears During Birth

Lifelong pelvic floor issues, such as incontinence, often ensue

Bictegravir-Lenacapavir Combo Pill Earns FDA Approval in Suppressed HIV

Combo could offer an alternative for those who can't take existing single-tablet regimens

Her Breast MRI Was Approved, but That Didn't Mean Her Insurance Would Pay

High-risk patients face steep, surprise bills for preventive breast MRIs

Lionel Richie Hospitalized; CDC Challenges Measles Toll; Vitamin K Refusals Rise

Health news and commentary gathered by MedPage Today staff

Nurse Who Saved Baby in Pakistan Hospital Fire Wishes She Could Have Saved the Rest

"I acted as a mother," she said

Gloria Steinem on Women's Rights, Abortion Politics, and Being Called the B-Word

And what she thought about Roe v. Wade being overturned

Judge Declares Mistrial in Lindsay Clancy Case

Defense attorney said she was suffering from postpartum psychosis when she strangled her kids

Judge Sends Deadlocked Lindsay Clancy Jurors Home

Foreperson said a single juror won't follow the court's instructions about reasonable doubt

One of the Lindsay Clancy Trial's Most Instructive Moments for Physicians

The author of a medical record doesn't always retain ownership of its meaning

Breast Cancer Drug Wins Approval Despite Rejection by Agency Advisors

Oral SERD camizestrant lands indication for use in novel first-line treatment strategy

Trump Pardon Sought for Clancy; Sen. Marshall's Medical Debt Suits; Lasker Winners

Health news and commentary gathered by MedPage Today staff

An Appeals Court Is Considering a Push to Restrict Most Common Abortion Method

The political situation is tricky for President Trump

Ectopic Pregnancy Deaths Have Nearly Doubled. It's Worse in Abortion-Ban States.

"This is a potentially profound consequence of the regulation," said one abortion policy expert

Residency Software Developer Sues Doctor Who Helped Launch a Competing Product

AAMC-partnered Thalamus goes after key players in ResidencyCAS

Bipartisan Campaign Pledges $100M to Cut U.S. Maternal Mortality Rate in Half

Problem is "eminently solvable," says president of Healthy Moms, Healthy Babies America

Recommended News For You

Research exposes far-reaching toll of financial hardship on patients with cancer

Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer

Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.

Brain MRI Surveillance Alone May Be Enough in SCLC

A new device enhances liquid biopsy.

Conditional EU Nod for Weekly Pill in Pediatric Glioma

DNA's hidden shape reveals target to reverse ovarian cancer chemoresistance

Recommended Articles For You

Developmental Pediatric Blood-Cell Production: Mechanisms, Clinical Implications, and Emerging Therapies 

Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment 

Mastering Oncology RCM: Reducing Errors, Denials & Improving Billing Efficiency 

Case-Based Learning on Functional Organ Preservation in Multistage Precision Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer

2.

CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma

3.

Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.

4.

Dual-action mRNA vaccine takes aim at aggressive skin cancer

5.

Ignoring Colonoscopy Advice; Dry Mouth Acupuncture; Inflamed Tongue, Then Cancer.

1.

Lymphomatoid Papulosis: What You Need to Know

2.

The Surprising Role of Magnesium in Digestion, Sleep and Mental Health 

3.

Public Health Strategies for Building Community-Based Precision Prevention Ecosystems

4.

Integrated Perspectives in Oncology in Clinical Decision-Making

5.

Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

1.

CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC

2.

Emerging Concepts in Hematology

3.

Efficient Management of First line ALK-rearranged NSCLC

4.

Understanding Blood Clotting Disorders

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot